Expression and clinical significance of FOXE1 in papillary thyroid carcinoma

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 123-127

  Fan, Youben ^a   Ding, Zheng ^a   Yang, Zhili ^a   Deng, Xianzhao ^a   Kang, Jie ^a   Wu, Bo ^a   Zheng, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Clinical significance; FOXE1 expression; Papillary thyroid carcinoma

Indexed keywords

BETA ACTIN; FORKHEAD BOX PROTEIN E1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; THYROID CARCINOMA; TUMOR INVASION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RNA, MESSENGER; THYROID NEOPLASMS;

EID: 84878941726     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1494     Document Type: Article

References (20)

1. Davies L and Welch HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167, 2006.
2. Hay ID, Thompson GB, Grant CS, et al: Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26: 879-885, 2002. (Pubitemid 36920280)
3. Zannini M, Avantaggiato V, Biffali E, et al: TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 16: 3185-3197, 1997. (Pubitemid 27234957)
4. Katoh M and Katoh M: Human FOX gene family (Review). Int J Oncol 25: 1495-1500, 2004.
5. Dathan N, Parlato R, Rosica A, De Felice M and Di Lauro R: Distribution of the titf2/foxe1 gene product is consistent with an important role in the development of foregut endoderm, palate and hair. Dev Dyn 224: 450-456, 2002. (Pubitemid 34848069)
6. De Felice M, Ovitt C, Biffali E, et al: A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 19: 395-398, 1998. (Pubitemid 28357915)
7. Brune K, Hong SM, Li A, et al: Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiol Biomarkers Prev 17: 3536-3542, 2008.
8. Weisenberger DJ, Trinh BN, Campan M, et al: DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res 36: 4689-4698, 2008.
9. Venza I, Visalli M, Tripodo B, Lentini M, Teti D and Venza M: Investigation into FOXE1 genetic variations in cutaneous squamous cell carcinoma. Br J Dermatol 162: 681-683, 2010.
10. Sequeira MJ, Morgan JM, Fuhrer D, Wheeler MH, Jasani B and Ludgate M: Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid 11: 995-1001, 2001. (Pubitemid 33107910)
11. Gudmundsson J, Sulem P, Gudbjartsson DF, et al: Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41: 460-464, 2009.
12. Nam KH, Noh TW, Chung SH, et al: Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinorma. Thyroid 21: 745-750, 2011.
13. Shaha AR: TNM classification of thyroid carcinoma. World J Surg 31: 879-887, 2007.
14. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19: 1167-1214, 2009.
15. Hannenhalli S and Kaestner KH: The evolution of Fox genes and their role in development and disease. Nat Rev Genet 10: 233-240, 2009.
16. Sizemore ST and Keri RA: The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression. J Biol Chem 287: 24631-24640, 2012.
17. Nucera C, Eeckhoute J, Finn S, et al: FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res 15: 3680-3689, 2009.
18. Bellelli R, Castellone MD, Garcia-Rostan G, et al: FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Endocr Relat Cancer 19: 695-710, 2012.
19. Matsuse M, Takahashi M, Mitsutake N, et al: The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 48: 645-648, 2011.
20. Xu X, Ding H, Rao G, et al: Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer 19: 167-179, 2012.